PSMD11 and pancreatic ductal adenocarcinoma: Analysis of the patients’ clinical data revealed that the expression of both PSMD11 and PSMD14 was significantly correlated with lymph node metastasis, TNM grade, degree of differentiation, and poor prognosis in pancreatic ductal adenocarcinoma patients.